LO
Lotus Eye Hospital And Institute Ltd
LOTUSEYE.BO · BSE
₹113.25 +2.03% (+₹2.25)
1M -1.78%
Market Cap ₹2.36B
P/E Ratio 1,577.48x
Div. Yield -
ROE 0.25%
Bulios Fair Price
₹70.37
37.9% downside
Current Price
₹113.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LOTUSEYE.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
15 /100
Expensive P/S 4.11x
P/E 1,577.48x
P/B 3.92x
Growth
33 /100
Declining Book val. growth 3.19%
EPS growth 38.19%
Rev. growth 8.40%
Profitability
12 /100
Weak Op. margin 0.50%
Gross margin 25.47%
FCF margin 0.47%
Quality
0 /100
Poor ROE 0.25%
Asset turnover N/A
ROIC N/A
Debt
79 /100
Low Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Int. coverage 0.83x
Stability
69 /100
Stable EPS volatility 56.14%
Beta 0.49x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LOTUSEYE.BO
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
S. K. Sundaramoorthy
Employees
402
Headquarters
Coimbatore